Published in Trans R Soc Trop Med Hyg on March 01, 1990
The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). PLoS Negl Trop Dis (2010) 1.81
Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis (2014) 1.68
Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature. Filaria J (2007) 1.59
A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis (2013) 1.42
Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis. PLoS Negl Trop Dis (2010) 1.10
Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia. Filaria J (2005) 0.92
The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014). Infect Dis Poverty (2016) 0.80
A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti. Am J Trop Med Hyg (2013) 0.78
Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg (1991) 3.31
Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis (2002) 3.13
Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol (2001) 2.94
Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today (1997) 2.83
Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg (2003) 2.49
Diagnosis of malaria in the field by fluorescence microscopy of QBC capillary tubes. Trans R Soc Trop Med Hyg (1992) 2.39
Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet (1993) 2.23
Evaluating orangutan census techniques using nest decay rates: implications for population estimates. Ecol Appl (2008) 2.09
Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg (1991) 1.87
Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol (2000) 1.78
Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J Infect Dis (1995) 1.74
Epitope specificity of the T cell proliferative response to lysozyme: proliferative T cells react predominantly to different determinants from those recognized by B cells. Eur J Immunol (1980) 1.62
A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. J Immunol (2001) 1.60
Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol (1993) 1.51
The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun (2000) 1.50
Proteins secreted by the parasitic nematode Nippostrongylus brasiliensis act as adjuvants for Th2 responses. Eur J Immunol (2000) 1.49
Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect Immun (2000) 1.46
Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol (2001) 1.43
Infection of IL-4-deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response. J Immunol (1995) 1.40
Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy (2009) 1.33
Immunological focusing by th mouse major histocompatibility complex: mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes. Eur J Immunol (1982) 1.29
APC from mice harbouring the filarial nematode, Brugia malayi, prevent cellular proliferation but not cytokine production. Int Immunol (1996) 1.28
Performance of the OptiMAL assay for detection and identification of malaria infections in asymptomatic residents of Irian Jaya, Indonesia. Am J Trop Med Hyg (2001) 1.26
Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am J Trop Med Hyg (1993) 1.26
Expression and immune recognition of Brugia malayi VAL-1, a homologue of vespid venom allergens and Ancylostoma secreted proteins. Mol Biochem Parasitol (2001) 1.26
Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection. J Immunol (1990) 1.26
Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet (1995) 1.25
Shared carbohydrate epitopes on distinct surface and secreted antigens of the parasitic nematode Toxocara canis. J Immunol (1987) 1.25
Absence of malaria mortality in villagers with chloroquine-resistant Plasmodium falciparum treated with chloroquine. Trans R Soc Trop Med Hyg (1984) 1.21
Adult and microfilarial stages of the filarial parasite Brugia malayi stimulate contrasting cytokine and Ig isotype responses in BALB/c mice. J Immunol (1994) 1.20
Nippostrongylus brasiliensis: cytokine responses and nematode expulsion in normal and IL-4-deficient mice. Exp Parasitol (1996) 1.20
Serine proteinase inhibitors from nematodes and the arms race between host and pathogen. Trends Biochem Sci (2001) 1.19
Understanding the impacts of land-use policies on a threatened species: is there a future for the Bornean orang-utan? PLoS One (2012) 1.18
Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis. Trop Med Int Health (2003) 1.18
Comparative performance of the ParaSight F test for detection of Plasmodium falciparum in malaria-immune and nonimmune populations in Irian Jaya, Indonesia. Bull World Health Organ (1997) 1.18
Characterization of surface and excretory-secretory antigens of Toxocara canis infective larvae. Parasite Immunol (1984) 1.17
A novel member of the transforming growth factor-beta (TGF-beta) superfamily from the filarial nematodes Brugia malayi and B. pahangi. Exp Parasitol (1998) 1.16
Identification of abundantly expressed novel and conserved genes from the infective larval stage of Toxocara canis by an expressed sequence tag strategy. Infect Immun (1999) 1.15
T cell responsiveness correlates differentially with antibody isotype levels in clinical and asymptomatic filariasis. J Infect Dis (1993) 1.14
Immunology of human helminth infection. Int Arch Allergy Immunol (1996) 1.12
Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya. Am J Trop Med Hyg (1991) 1.12
Depression of antigen-specific interleukin-5 and interferon-gamma responses in human lymphatic filariasis as a function of clinical status and age. J Infect Dis (1997) 1.11
Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg (1995) 1.10
An abundant, trans-spliced mRNA from Toxocara canis infective larvae encodes a 26-kDa protein with homology to phosphatidylethanolamine-binding proteins. J Biol Chem (1995) 1.10
Toxocara canis: a labile antigenic surface coat overlying the epicuticle of infective larvae. Exp Parasitol (1992) 1.09
Helminth C-type lectins and host-parasite interactions. Parasitol Today (2000) 1.09
Nematode surface coats: actively evading immunity. Parasitol Today (1992) 1.08
A novel serpin expressed by blood-borne microfilariae of the parasitic nematode Brugia malayi inhibits human neutrophil serine proteinases. Blood (1999) 1.08
Heightened transmission of stable malaria in an isolated population in the highlands of Irian Jaya, Indonesia. Am J Trop Med Hyg (1992) 1.07
Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol (1991) 1.06
An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteins. Proc Natl Acad Sci U S A (1996) 1.05
A novel C-type lectin secreted by a tissue-dwelling parasitic nematode. Curr Biol (1999) 1.04
A focus of human infection by Haplorchis taichui (Trematoda: Heterophyidae) in the southern Philippines. J Parasitol (2004) 1.04
Differentially expressed, abundant trans-spliced cDNAs from larval Brugia malayi. Mol Biochem Parasitol (1997) 1.04
Specificity of surface molecules of adult Brugia parasites: cross-reactivity with antibody from Wuchereria, Onchocerca and other human filarial infections. Trop Med Parasitol (1985) 1.04
Biochemical properties of larval excretory-secretory glycoproteins of the parasitic nematode Toxocara canis. Mol Biochem Parasitol (1986) 1.04
Differential decline in filaria-specific IgG1, IgG4, and IgE antibodies in Brugia malayi-infected patients after diethylcarbamazine chemotherapy. J Infect Dis (1995) 1.03
Restricted sets of parasite antigens from the surface of different stages and sexes of the nematode parasite Nippostrongylus brasiliensis. Immunology (1983) 1.03
Acquired immune heterogeneity and its sources in human helminth infection. Parasitology (2010) 1.03
A family of secreted mucins from the parasitic nematode Toxocara canis bears diverse mucin domains but shares similar flanking six-cysteine repeat motifs. J Biol Chem (2000) 1.03
Characterization of nematode glycoproteins: the major O-glycans of Toxocara excretory-secretory antigens are O-methylated trisaccharides. Glycobiology (1991) 1.00
Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites. J Immunol (1998) 0.99
Allelic variants of the Plasmodium falciparum merozoite surface antigen 2 (MSA-2) in a geographically restricted area of Irian Jaya. Mol Biochem Parasitol (1994) 0.99
Diagnosis of human toxocariasis by antigen capture enzyme linked immunosorbent assay. J Clin Pathol (1993) 0.98
The serpin secreted by Brugia malayi microfilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans. J Immunol (2000) 0.97
Molecules on the surface of parasitic nematodes as probes of the immune response in infection. Immunol Rev (1982) 0.97
Repeated patent infection of adult dogs with Toxocara canis. J Helminthol (1984) 0.96
Phosphorylcholine-bearing antigens in filarial nematode parasites: analysis of somatic extracts, in-vitro secretions and infection sera from Brugia malayi and B. pahangi. Parasite Immunol (1987) 0.96
Conditions for the development of IgM- and IgG-antibody-secreting cells from primed mouse splenocytes in vitro. Immunology (1977) 0.96
Antibody responses to filarial infective larvae are not dominated by the IgG4 isotype. Parasite Immunol (1998) 0.95
Identification, synthesis and immunogenicity of cuticular collagens from the filarial nematodes Brugia malayi and Brugia pahangi. Mol Biochem Parasitol (1989) 0.94
Identification of a new C-type lectin, TES-70, secreted by infective larvae of Toxocara canis, which binds to host ligands. Parasitology (2000) 0.94
Species-specific and common epitopes on the secreted and surface antigens of Toxocara cati and Toxocara canis infective larvae. Parasite Immunol (1987) 0.94
Heat shock cognate 70 is a prominent immunogen in Brugian filariasis. J Immunol (1989) 0.94
daf-7-related TGF-beta homologues from Trichostrongyloid nematodes show contrasting life-cycle expression patterns. Parasitology (2009) 0.93
Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites. J Immunol (1998) 0.93
Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. Am J Trop Med Hyg (2002) 0.93
High prevalence of Brugia timori infection in the highland of Alor Island, Indonesia. Am J Trop Med Hyg (2002) 0.93
Cuticular localisation and turnover of the major surface glycoprotein (gp29) of adult Brugia malayi. Mol Biochem Parasitol (1990) 0.92
Plasmodium ovale in the highlands of Irian Jaya, Indonesia. Ann Trop Med Parasitol (1992) 0.92
Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia. Filaria J (2005) 0.92
Low dosage diethylcarbamazine administered by villagers for the control of timorian filariasis. Trans R Soc Trop Med Hyg (1984) 0.91
Adults acquire filarial infection more rapidly than children: a study in Indonesian transmigrants. Parasitology (2001) 0.91
Secreted and circulating antigens of the filarial parasite Brugia pahangi: analysis of in vitro released components and detection of parasite products in vivo. Mol Biochem Parasitol (1985) 0.90
Ascaris suum-derived products induce human neutrophil activation via a G protein-coupled receptor that interacts with the interleukin-8 receptor pathway. Infect Immun (2001) 0.90
Brugia pahangi and Brugia malayi: a surface-associated glycoprotein (gp15/400) is composed of multiple tandemly repeated units and processed from a 400-kDa precursor. Exp Parasitol (1993) 0.90
Cross-reactive surface antigens on three stages of Brugia malayi, B. pahangi and B. timori. Parasitology (1983) 0.89
Stage-specific antigens of Nematospiroides dubius. Immunology (1984) 0.89
Malaria vaccine study site in Irian Jaya, Indonesia: Plasmodium falciparum incidence measurements and epidemiologic considerations in sample size estimation. Am J Trop Med Hyg (1994) 0.89
Characterization of proteolytic enzymes from larval and adult Nippostrongylus brasiliensis. Parasitology (1991) 0.89
Toxocara canis: monoclonal antibodies to carbohydrate epitopes of secreted (TES) antigens localize to different secretion-related structures in infective larvae. Exp Parasitol (1992) 0.89
The antibody recognition profiles of humans naturally infected with Ascaris lumbricoides. Parasite Immunol (1989) 0.89
In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Am J Trop Med Hyg (1999) 0.88
Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunol (2011) 0.88
Persistent airway hyper-responsiveness and inflammation in Toxocara canis-infected BALB/c mice. Clin Exp Allergy (2005) 0.88
Ir-gene control of T cell proliferative responses: two distinct expressions of the genetically nonresponsive state. Eur J Immunol (1980) 0.87
cDNA clones of Onchocerca volvulus low molecular weight antigens provide immunologically specific diagnostic probes. Mol Biochem Parasitol (1991) 0.87
Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia. Am J Trop Med Hyg (1999) 0.87
A cDNA encoding Tc-MUC-5, a mucin from Toxocara canis larvae identified by expression screening. Acta Trop (2001) 0.87
The use of mebendazole in the treatment of polyparasitism. Southeast Asian J Trop Med Public Health (1974) 0.86